Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

HC Wainwright & Co. Reiterates Buy on Aura Biosciences, Maintains $22 Price Target

Author: Benzinga Newsdesk | August 13, 2025 12:36pm
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 price target.

Posted In: AURA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist